Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V de Haas

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
European Biophysics Journal : EBJ|January 1, 1989
Sodium and potassium currents recorded during an action potentialV de Haas, W Vogel
Expert Review of Anticancer Therapy|March 12, 2021
Measurable residual disease in pediatric acute myeloid leukemia: a systematic reviewW H Segerink, V de Haas, G J L Kaspers
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Risk assessment in ALL in children: a focus on PCR-based techniques for MRD detectionV de Haas, C E van der Schoot, H van den Berg
Nederlands Tijdschrift Voor Geneeskunde|April 15, 1995
[Treatment of anemia in premature infants using recombinant human erythropoietin]V de Haas, B C Raaijmaakers, B A Semmekrot, et al.
The Veterinary Record|December 6, 1986
Progesterone therapy in mares with abnormal oestrous cyclesD R Rutten, S Chaffaux, M Valon, et al.
The Veterinary Record|September 17, 2011
Efficacy and safety of a new 450 mg/ml florfenicol formulation administered intramuscularly in the treatment of bacterial bovine respiratory diseaseJ Thiry, S Rubion, P Sarasola, et al.
Pediatrics|February 24, 2001
Meconium aspirationM O Hoekstra, V de Haas, W M van Alderen, et al.
Avian Pathology : Journal of the W.V.P.A|December 15, 2010
Safety and efficacy of a maternal vaccine for the passive protection of broiler chicks against necrotic enteritisC F Crouch, G S K Withanage, V de Haas, et al.
Leukemia|November 7, 2008
Gene expression profile of slowly responding subclones might represent different profiles already at diagnosis and might be used for prediction of outcomeV de Haas, R Dee, G Cheroutre, et al.
Blood|September 9, 2000
Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapseV de Haas, W B Breunis, O J Verhagen, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
European Biophysics Journal : EBJ|January 1, 1989
Sodium and potassium currents recorded during an action potentialV de Haas, W Vogel
Expert Review of Anticancer Therapy|March 12, 2021
Measurable residual disease in pediatric acute myeloid leukemia: a systematic reviewW H Segerink, V de Haas, G J L Kaspers
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Risk assessment in ALL in children: a focus on PCR-based techniques for MRD detectionV de Haas, C E van der Schoot, H van den Berg
Nederlands Tijdschrift Voor Geneeskunde|April 15, 1995
[Treatment of anemia in premature infants using recombinant human erythropoietin]V de Haas, B C Raaijmaakers, B A Semmekrot, et al.
The Veterinary Record|December 6, 1986
Progesterone therapy in mares with abnormal oestrous cyclesD R Rutten, S Chaffaux, M Valon, et al.
The Veterinary Record|September 17, 2011
Efficacy and safety of a new 450 mg/ml florfenicol formulation administered intramuscularly in the treatment of bacterial bovine respiratory diseaseJ Thiry, S Rubion, P Sarasola, et al.
Pediatrics|February 24, 2001
Meconium aspirationM O Hoekstra, V de Haas, W M van Alderen, et al.
Avian Pathology : Journal of the W.V.P.A|December 15, 2010
Safety and efficacy of a maternal vaccine for the passive protection of broiler chicks against necrotic enteritisC F Crouch, G S K Withanage, V de Haas, et al.
Leukemia|November 7, 2008
Gene expression profile of slowly responding subclones might represent different profiles already at diagnosis and might be used for prediction of outcomeV de Haas, R Dee, G Cheroutre, et al.
Blood|September 9, 2000
Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapseV de Haas, W B Breunis, O J Verhagen, et al.
Pageof 5